However, we here define such an auxiliary drug from two perspectives: (a) its protective effect from CP‐associated side effects and (b) its neutral or favorable influence on the cytotoxic effect of CP on (platinum‐resistant) tumor cells. The gene discussed is CP; the disease is neoplasm.